Matritech Awarded Patent for NMP Tech
Matritech said this week it has received a patent covering methods for detection of cancer using nuclear matrix proteins in bodily fluids such as blood and urine.
The patent, No. 6,740,494, covers technology that is used in the company’s diagnostic products for detection of bladder cancer, the company said.
Matritech, of Newton, Mass., has licensed this nuclear matrix protein technology exclusively from the Massachusetts Institute of Technology.